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ABSTRACT
Chitosan is known to be antibacterial and antifungal, but information on its
effectiveness against foodborne viruses is limited. Enteric viruses are a major concern in
food safety, especially human noroviruses which are the leading cause of nonbacterial
gastroenteritis. The overall goal of this research was to determine the antiviral
effectiveness of chitosan. The specific objectives were to determine the effects of
molecular weight (MW) and concentration of chitosan against the cultivable enteric viral
surrogates, feline calicivirus (FCV-F9), murine norovirus (MNV-1), and bacteriophages
(MS2 and phiX174). Purified chitosans (53, 222, 307, 421, ~1,150kDa) were dissolved in
water, 1% acetic acid, or aqueous HCl (pH= 4.3), and sterilized by membrane filtration.
The solutions were mixed with equal volume of virus suspension to obtain a virus titer of
5 log PFU/ml and chitosan concentration of 0.7% for all five MW and 0.7, 1.0, 1.25, and
1.5% for 53 and 222kDa. The samples were incubated for 3 hr at 37°C before viral
enumeration. Controls included untreated viruses in PBS, in PBS with acetic acid, and in
PBS with HCl. Chitosan showed the greatest reduction of MS2, followed by FCV-F9, phi
X174, and MNV-1. A MW effect was seen with MS2, with higher MW being more
efficient, and 0.7% of ~1,150kDa causing complete inactivation. Increasing the
concentration of chitosan from 0.7 to 1.5% reduced the titer of MS2 and FCV-F9 by 5.16
and 2.91 logs, respectively. Although chitosan was ineffective against MNV-1, its ability
to significantly reduce MS2 and FCV-F9, suggest its use for future foodborne viral
control.
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CHAPTER I
INTRODUCTION
Foodborne disease outbreaks, especially those caused by viruses, have become a
major concern in the food industry. Chitosan has shown promise as a potential
antimicrobial (Devlieghere et al., 2004), food additive, such as a clarifying agent or
antioxidant, (Shahidi et al., 1999), and packaging material (Shahidi et al., 1999) and has
been approved by EPA as a biopesticide (Docket No. EPA-HQ-OPP-2007-0566-0019).
Therefore, this study was done to determine the effectiveness of chitosan against
surrogates of enteric viruses commonly associated with foodborne outbreaks.
The overall goal of this research was to determine antiviral efficiency of chitosan.
The specific objectives were:
1. To determine the effect of chitosan against the enteric virus surrogates phi X174,
MS2, feline calicivirus (FCV-F9), and murine norovirus (MNV-1).
2. To determine the effect of molecular weight (MW) of chitosan, ranging from 53
to ~1,150 kDa.
3. To determine the effect of concentration of chitosan (0.7- 1.5%) on the enteric
virus surrogates

1.2 Hypotheses

The hypotheses for these objectives were as follows:
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1. Increasing the molecular weight of chitosan would increase the antiviral activity
because the longer chains would able to wrap around and damage the viral
structure more than the lower molecular weight.
2. Increasing the concentration would improve the antiviral activity of chitosan due
to more positive charges being able to interact with negatively charged
components of the viral capsid.

1.3 Explanation for molecular weights and concentrations chosen

The molecular weights of chitosan chosen for this study covered the majority of
the chitosan molecular weight spectrum. Molecular weight chitosan lower than 50
kDa was not used because the study by Su et al. (2009) already determined that they
were not effective against these surrogates.Similarly, the concentrations of 0.7% and
above were selected because the effect of lower concentration was already reported in
literature (Su et al., 2009). However, the increase in chitosan concentration was
limited to 1.5% due to the increase in the viscosity.
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CHAPTER II
LITERATURE REVIEW

1.1.

Chitosan

Chitosan, a linear cationic polysaccharide, is a deacteylated derivative of chitin,
which is the second most abundant polysaccharide in nature. Chitin is the major structural
biopolymer in crustacean shells, fungi, and insects (Roller et al. 1999) and chitosan is
naturally present in some fungi, such as zygomycetes (Shahidi et al., 1999). Chitosan is
composed of at least 70% glucosamine and no more than 30% acetyl-glucosamine units
bound by β (1-4) glycosidic bonds. It is typically described by its molecular weight
(MW), which ranges between 50-1000 kDa, and degree deacetylation (DDA), which
ranges between 70-100%. Although chitosan is approved as a food additive in food in
Japan and Korea (No et al., 2007), it is not generally recognized as safe (GRAS) in the
United States. However, it has been accepted as a bio pesticide (Docket No. EPA-HQOPP-2007-0566-0019), sold as a dietary supplement, and allowed as an additive to dog
food (Park et al., 2002). Chitosan is used to form gels, films, beads, and fibers (Guibal
2004; Sankararamakrishnan et al., 2006; Zivanovic et al. 2008), in waste water
management as a chelator (Shahidi et al., 1999), and in medicine as wound dressings
(Koide, 1998). Chitosan has been researched for use in the food industry in various fields,
including as an antimicrobial, antioxidant, thickening agent in beverages, clarifying agent
in juice, and as a packaging material (Devlieghere et al., 2004; Shahidi et al., 1999; Xie et
al., 2001).
4

Since a major source of chitosan is shellfish waste and shellfish is one of the most
common allergens, there is a concern that chitosan might act as an allergen as well.
However, Gray et al. (2004) determined that it was safe for people with shellfish allergies
to use glucosamine supplements because it is the proteins of the flesh of the fish, and not
the shell, that cause the reaction. Furthermore, the extraction and preparation of chitosan
should remove all proteins including those that may be potential allergens (Muzzarelli
2010). Due to the aggressive chemical processes used to extract chitin and produce
chitosan, the product should not be considered as part of the living organism that
biosynthesized it, just as the maize starch is not considered part of maize plant after the
wet milling (Muzzarelli, 2010).

1.2.

Mechanisms of antibacterial action of chitosan

Antibacterial properties of chitosan have been widely investigated and confirmed
(Coma et al., 2003; Dutta et al., 2009; Kong et al., 2008; Liu et al., 2004; Zivanovic et al.,
2004). However, there are several mechanisms that have been proposed to explain the
antimicrobial mechanisms of chitosan. The first proposed antibacterial mechanism of
chitosan occurs due to electrostatic interactions between the chitosan amine group and the
negatively charged components (lipopolysaccharides and proteins) of the outer cell
causing distortion of the cellular membrane and leakage of intracellular material (Coma
et al., 2003; Dutta et al., 2009; Helander et al., 2001; Kong et al., 2008; Liu et al., 2004).
A study by Liu et al. (2004) treated S. aureus and E. coli with 0.5 and 0.25% 78 kDa
chitosan causing a 1 log reduction after 5 min, complete inactivation of E. coli after 120
5

min, and no change in S. aureus after 120 min. The cells were examined by transmission
electron microscope and E. coli was found to have an altered and chitosan-covered outer
membrane, but no damage to the inner membrane. On the other hand, S. aureus showed
leakage of intracellular material and new cells were found to form without membranes or
cell walls on the outside. Another study by Helander et al. (2001), treated E. coli and S.
Typhimurium with 0.025% of 85% DDA chitosan, which altered the outer membrane of
the cell and formed a layer around E. coli.
Zheng and Zhu (2003) suggested that chitosan interrupts the physiological
activities of the cell, but affects Gram positive and Gram negative cells differently. They
proposed that higher molecular weight chitosan forms a polymer membrane to prevent
nutrients from leaving and entering the cell on Gram positive organisms, while lower
molecular weight chitosan enters the Gram negative cell binding to electronegative
substances, which causes flocculation in the cytoplasm and disruption of physiological
processes (Zheng and Zhu, 2003).
The third proposed mechanism of action is the inhibition of mRNA and protein
synthesis by penetrating the cell of the microorganism and binding with DNA (Sudarshan
et al., 1992). Still another proposed antibacterial mechanism of chitosan is the chelation
of essential nutrients needed for growth (Dutta et al., 2009). Kong et al. (2008) found that
chitosan microspheres of 1456 kDa were chelating Mg2+ of the E. coli outer membrane
causing destabilization of the cell. Still, the antibacterial property of chitosan could be a
combination of all the proposed mechanisms of action depending on the type of
microorganism and characteristics of chitosan.
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1.3.

Mechanisms of antifungal properties of chitosan

Similar mechanisms have been proposed for antifungal activity of chitosan. The
first mechanism involves the interaction of chitosan with the cell plasma membrane
causing leakage of intracellular material (El Ghaouth et al., 1992; Liu et al., 2007).
Badaway et al. (2004) used chitosan and chitosan derivatives of less than 120 kDa (85%
DDA) at 1% concentrations to find that Botrytis cinerea growth was reduced most likely
due to chitosan causing a permeability change in the plasma membrane. Seyfarth et al.
(2008) found that 120 kDa chitosan hydrochloride against Candida albicans, C. krusei,
and C. glabrata caused disruption of the plasma membrane leading to permeable cells.
Guerrero et al. (2005) found 0.1% chitosan to inhibit the growth and cause about a 1 log
reduction in the first few min of treatment by causing structural defects in the cell wall of
Saccharomyces cerevisiae. One study found chitosan to be effective at controlling B.
cinerea infection in strawberries by either inducing natural plant resistant mechanisms or
able to control its growth through fungistatic properties (Reddy et al., 2000). A second
proposed mechanism involves the accumulation of chitosan in the cell wall to inhibit
growth (El Ghaouth et al., 1992). El Ghaouth et al. (1992) found that chitosan caused
leakage of amino acids as well as morphological changes due to the accumulation of
chitosan in the cell wall of Rhizopus stolinfer and B. cinerea. The third proposed
mechanism involves the chelation of Ca2+, Zn2+, and other essential minerals needed for
growth (Cuero et al., 1991; Roller et al., 1999). A study by Roller et al. (1999) found that
chitosan reduced the growth rates of Mucor racemosus by making Ca2+ and other
essential minerals unavailable. The last proposed mechanism involves chitosan
7

interfering with conformation or physical properties of DNA in Fusarium solani
(Hadwiger et al., 1981). Hadwiger et al. (1981) also found that 0.0002% of chemically
cleaved chitosan applied to pea plants 24 hr in advance was able to protect against F.
solani.

1.4.

Antiviral properties of chitosan

The proposed antiviral mechanisms of chitosan are similar to the antifungal and
antibacterial mechanisms, but vary depending on chitosan being applied pre-harvest or
post-harvest. Most of the antiviral activity of chitosan has been studied on plants at preharvest. Chitosan has been shown to exhibit indirect antiviral activity at pre-harvest by
penetrating the plant cell to induce resistance (Kulikov et al., 2006). On tobacco necrosis
virus, 0.15% 76 kDa chitosan caused a 95.2% reduction by inducing abscisic acid
production causing plant resistance to the virus (Iriti and Faoro, 2008).
The first proposed post-harvest mechanism is that chitosan causes structural
damage to the virus (Kochkina et al., 2000a). Kochkina et al. (2000c) through electron
microscopy have seen chitosan to cause loss in viral tail fibers with receptors and viral
sheath contraction exposing DNA of phage T2 and 1-97A. Another mechanism proposes
that chitosan interacts with the negative charge of the viral capsids (Kochkina et al.,
2000b; Su et al., 2009). Su et al. 2009 found 0.7% 53 kDa chitosan caused a 1.7 log
reduction of MS2, which could be due to the negatively charged MS2, which has an
isoelectric point of 3.9 (Langlet et al., 2007), binding to the positively charged chitosan.
The third proposed mechanism involves inhibiting phage infection (Kochkina et al.,
8

1995). A study found chitosan to inhibit the lytic infection bacteriophage of
bacteriophage T2 and T7 after adsorption into the host by possibly attaching to the viral
particles in the cell (Kochkina et al. 1995). Still another mechanism proposed chitosan
interferes with a step in the replication process (Chirkov, 2002; Kochkina et al., 2000a).
Kochkina et al. (2000a) found chitosan to be efficient at inhibiting phage replication of
bacteriophage 1-97A in B. thuringiensis, which the authors thought to be due to the
interruption of the intracellular reproduction of the phages. However, the effect of
chitosan on foodborne viruses needs to be studied futher in order to gain a better
understanding of effectiveness and mechanisms.

1.5.

Effect of molecular weight on chitosans antimicrobial properties

Molecular weight (MW) is thought to play an important role in the antimicrobial
effect of chitosan. Zheng and Zhu (2003) studied the effect of different molecular weights
on Gram positive (S. aureus) and Gram negative (E. coli) bacteria. They found that as
MW increased from less than 5 kDa to 305 kDa the antibacterial activity increased
against Gram positive bacteria and decreased against Gram negative bacteria. The authors
found the lower MW (<5 kDa at 0.25% concentration) inhibited gram negative E. coli by
entering the cell and interrupting physiological activities of the cell, while the higher
molecular weight (166 and 305 kDa at 0.25% concentration) inhibited Gram positive S.
aureus by damaging the cell membrane. Devlieghere et al. (2004) determined that Gram
negative bacteria were very susceptible to the effects of 43 kDa chitosan and that Gram
positive bacteria varied greatly in response to the chitosan with some being inhibited,
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while others were less affected. Zivanovic et al. (2004) found that 150 kDa chitosan
inhibited Gram positive Listeria monocytogenes and Gram negative Salmonella
Typhimurium better than ~5 kDa chitosan. Even No et al. (2002) found that chitosan
between 28 – 1671 kDa inhibited the growth of both Gram negative (E. coli,
Pseudomonas fluorescens, Salmonella Typhimurium, and Vibrio parahaemolyticus) and
Gram positive (Listeria monocytogenes, Bacillus cereus, Staphylococcus aureus,
Lactobacillus plantarum, Lactobacillus brevis, and Lactobacillus bulgaricus) bacteria
better than 1-22 kDa chitosan oligomers. Nevertheless, Gerasimenko et al. (2004) found
that chitosans between 5 and 27 kDa were able to effectively inhibit Gram positive and
Gram negative bacteria. Li et al. (2009) used 3, 50, and 1000 kDa chitosan to find that all
three chitosans caused cellular membrane damage in E. coli, but 50 kDa caused the most.
Effect of molecular weight of chitosan against viruses has mostly been studied
indirectly, in vivo.as chitosan increases plant resistance to viral attack. Chirkov et al.
(1998) found that as the molecular weight of chitosan increased from 3, 8, to 50 kDa, the
resistance of bean plants to bean mild mosaic virus increased. However, another study
found the opposite trend for the same virus. This study used chitosan of 1.2, 2.2, 10.1,
30.3, and 40.4kDa to find that bean plants resistance to bean mild mosaic virus increased
as MW decreased (Kulikov et al. 2006). A study by Su et al. (2009) has been done on the
direct effects of chitosan of different molecular weights on human noroviruses surrogates,
which showed an increasing antiviral activity trend. The authors found that 53 kDa
chitosan reduced viral titers of bacteriophage MS2 and FCV-F9 by 1.70 and 4.21 log
PFU/ml, respectively, while 5 kDa chitosan was only 0.98 and 1.41 log PFU/ml,
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respectively. Su et al. (2009) also showed that chitosan was ineffective at inactivating
MNV-1.

1.6.

Effect of concentration on chitosans antimicrobial properties

Chitosan concentration is another factor thought to play an important role in
determining the antimicrobial effect. In one study, chitosan of 78 kDa at 0.25 and 0.5%
found that 0.5% chitosan showed more membrane damage of S. aureus and E. coli than
0.25% (Liu et al. 2004). Chitosan has been shown to disrupt outer membranes of S.
Typhimurium at 0.01- 0.025%, but were unable to kill Gram negative bacteria until
reaching 2% (Helander et al. 2001). One study found that antibacterial activity against S.
Typhimurium, E. coli, and Y. enterocolitica increased as the concentration of chitosan
increased from 0.5 to 2.5% (Wang, 1992). Kong et al. (2008) found an increase in
antibacterial activity against E. coli as the concentration of 1456 kDa chitosan was
increased from 0.02 to 0.1%. Zheng and Zhu (2003) found that as the concentration of <5
- 305 kDa chitosan increased from 0.25% to 1.0%, E. coli and S. aureus were reduced
from little or no change to complete inactivation.
Chitosan concentration has also been shown to affect the antiviral activity. Kochkina
et al. (1995) saw chitosan, chitosan acetate, and chitosan hydrochloride cause an increase
from less than 50% to 100% infection inhibition against bacteriophage T2 and T7 as the
concentration of chitosan increased from 0.000005 to 0.01%. Su et al. (2009) found an
increase in concentration of both 53 kDa chitosan and 5 kDa chitosan from 0.175 to 0.7%
to cause a statistically significant increase in the reduction of ~105 log PFU/ml FCV-F9
11

and ~107 log PFU/ml FCV-F9, while 5 kDa chitosan also caused a statistically significant
increase in reduction of ~105 and ~107 log PFU/ml FCV-F9 and ~105 log PFU/ml MNV1. However, for the same concentrations of both chitosans, the antiviral activity of
chitosan either had no change or decreased against ~105 and ~107 log PFU/ml MS2 and
~107 log PFU/ml MNV-1 as chitosan concentration increased.

1.7.

Foodborne viruses

Foodborne illnesses caused by viruses, bacteria, and parasites are a major concern
for the food industry today. According to the latest estimations of foodborne illnesses in
the United States, 31 pathogens are responsible for 9.4 million foodborne illnesses,
55,961 hospitalizations, and 1,351 deaths (Scallan et al., 2011). Of these, viruses are
estimated to be the responsible for 59% of the total foodborne illnesses, 27% of the
hospitalizations, and 12% of the deaths (Scallan et al., 2011).
The major difference between viruses, bacteria, and fungi is that viruses need a
host cell to replicate. Foodborne viruses, especially enteric viruses, are typically spread
by the fecal-oral route as a result of contaminated food, water, contact surfaces and
people from poor sanitation practices by infected food handlers (Todd et al., 2008).
Foodborne viruses have the potential to be shed by infected people before, during, or
after symptoms occur, as well as by those who never show symptoms (Atmar et al., 2008;
Parashar et al., 1998). Foods commonly contaminated with foodborne viruses include
shellfish, fresh produce, fruits and juices, and other foods that do not undergo further
thermal processing (Baert et al., 2009; Sair et al., 2002).
12

Some viruses have the ability to be environmentally stable and resistant to
temperature, pH, and enzymes, such as enteric viruses (Jaykus et al., 2000; Scipioni et al.,
2008). The leading cause of foodborne non-bacterial gastroenteritis is due to the human
norovirus (Mead et al., 1999). In 1968, a school outbreak in Norwalk, Ohio resulted in
infected school children spreading the infection to family members, which eventually led
to an outbreak. The virus that was originally called the winter vomiting disease became
known as the ―Norwalk-like virus‖. In 1972, the virus was identified as a small round
shaped virus (Kapikan et al., 1996). Due to advancements in technology, the morphology
and phylogeny of the Norwalk-like virus are better understood and have resulted in name
change to the human norovirus (Lopman et al., 2008). The Norovirus genus is one of two
genera in the Caliciviridae family, which includes Norovirus, Vesivirus, Lagovirus, and
Sapovirus, that cause gastroenteritis outbreaks (D‘Souza et al., 2007). Human noroviruses
are single stranded, non-enveloped, positive sense RNA viruses, and icosahedral in
shape being about 27-38 nm in size (Green et al., 2001, Hyde et al., 2009; Taube et al.,
2010). The RNA genome of the norovirus is about 7.5kb in size, which contains a poly A
tail on the 3‘ end of the genome and a sequence that is 7,642 nucleotides long on the
other end (Jiang and Estes, 1990, D‘Souza et al., 2007; Scipioni et al., 2008).
The infection process of human noroviruses is not completely understood, but it is
thought that the infection starts with the virus binding to histo blood group antigens
(HBGAs), which are complex glycans on red blood cells in the gut, which initiates the
replication process (Donaldson et al., 2008; Perry and Wobus, 2010). The infection
consists of self-limiting symptoms, such as nausea, vomiting, diarrhea, and fever, which
typically resolve within 3 days (Cliver et al., 2002; Grohmann et al., 1981; Grove et al.,
13

2006; Patel et al., 2008). Children, the elderly, and the immunocompromised are the most
vulnerable people to a norovirus infection. Norovirus outbreaks occur mainly in closed
settings, such as hospitals, cruise ships, military bases, and day cares, due to the ease of
transmission through contamination (Widdowson et al., 2005). The ability of the virus to
spread easily could be due to low infectious doses, which requires only 10-100 particles,
length of shedding time, stability in a wide range of environments, and a lack of
immunity developed by people (Cheesbrough et al., 2000, Jaykus et al., 2000, Teunis et
al., 2008; Duizer et al., 2004). Human noroviruses have been detected for up to 7 days
after inoculation on Formica, ceramic, and stainless steel, and found to have a 2.3 log or
less reduction after 90 days in frozen storage on strawberries, raspberries, and blueberries
(Butot et al., 2008; D‘Souza et al. 2006).
In 2001, an outbreak of norovirus affecting 30 people in Sweden involved bakery
products with contaminated raspberries (Le Guyader et al., 2004). In July 2005, a
norovirus outbreak happened at a summer camp in California involving 15 children due
to a food handler not practicing proper hygiene (Barrabeig et al., 2010). In November
2007, a Swedish manufacturing company had 413 workers with gastroenteritis due to 2
food handlers contaminating tomatoes with norovirus (Zomer et al., 2010). On a cruise
ship in 2008, there was a norovirus outbreak involving 196 people as a result of improper
personal hygiene, which was spread through person to person contact (Vivancos et al.,
2010). In Spain, 59 students were involved in a norovirus outbreak as a result of
contamination by food handlers (Godoy et al., 2005). As a result of a patron with a
norovirus infection vomiting in a restaurant, there was an outbreak in which 52 people
became sick (Marks et al., 2000). There have many outbreaks of norovirus worldwide
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from 1995-2004 due to spread through water including pools, drinking water, fountains,
tap water, and municipal water at hotels, recreation centers, restaurants, and in
communities (Maunula, 2007).

1.8.

Enteric viral surrogates

Human noroviruses are currently not cultivable in a laboratory (Duizer et al.,
2004), which is why cultivable surrogates, such as feline calicivirus (FCV-F9), murine
norovirus (MNV-1), and coliphage MS2 are used in infectivity assays.
Feline calicivirus (FCV) has been commonly used as a surrogate for human
noroviruses due to their genetic similarity as they both belong to the Caliciviridae family
(Bidawid et al., 2000; D‘Souza et al., 2006). FCV is a positive sense single stranded RNA
virus with a genome about 7.7 kb (Radford et al., 2006). It is a member of the Vesivirus
genus and transmitted through the nasal, oral or conjunctival passage ways of cats
(Radford et al., 2006). Cells infected with FCV present a characteristic cytopathic effect
associated with cell rounding and membrane bulging due to an inhibition of cellular
protein synthesis (Knowles et al., 1988; Willcocks et al., 2004). FCV causes moderate to
severe acute oral and upper respiratory illness in cats, which can be characterized with
oral ulcerations, and ocular and nasal drainage (Duizer et al., 2004; Hurley et al., 2004;
Radford et al., 2006). It can also lead to lameness or limping disease and some more
virulent strains have lead to death (Duizer et al., 2004; Pederson et al., 2000; Radford et
al., 2006). FCV can be shed for up to 30 days, infective for up to a month in the
environment, and is typically prevalent in areas with large numbers of cats, such as
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animal shelters (Doultree et al., 1999; Radford et al., 2006). There are broad-spectrum
antibiotics and live-attenuated and inactivated vaccines used to control the spread of
FCV. The difference between FCV and the human norovirus is that FCV is a respiratory
virus, which is not adjusted to the environmental conditions of the intestinal tract, such as
low pH and high bile concentrations, versus the human norovirus being less susceptible
to the intestinal tract conditions because it is an enteric virus (Duizer et al., 2004; Perry et
al., 2009; Radford et al., 2007; Cannon et al., 2006).
A study found FCV to have a 3 log reduction after 24 and 8 hr at 37 and 56˚C,
respectively (Duizer et al., 2004). Gulati et al. (2001) found a 2 log reduction of FCV
after washing inoculated strawberries and lettuce for 10 min with water. Another study
found bleach at 50 and 100 ppm to cause a 2.2 and 2.6 log reduction, respectively, on
lettuce after 2 min (Allwood et al. 2004). Allwood et al. (2003) found a FCV titer of 109
log PFU/ml in tap water to have a 1 log reduction after 7.7, 5.7, and 3.0 days at 4, 25, and
37˚C, respectively. Su et al. (2010c) found high intensity ultrasound at 20 kHz at < 21˚C
to cause a 2.67 log reduction and complete inactivation after 30 min to FCV in PBS with
a 106 and 104 titer, respectively. A 105 titer of FCV was treated with PBS at pH 7.0, PBS
at pH 2.6, orange juice at pH 3.8, orange juice at pH 3.4, cranberry juice at pH 2.6, and
cranberry juice at pH 7.0 to find a 0.12, 1.67, 1.40, 4.29, ,5.02, and 5.02 log reduction,
respectively (Su et al. 2010a). D‘Souza and Su (2010) found 2% trisodium phosphate to
be enough to completely inactivate both a low titer (105) and a high titer (107). The same
study found 10% bleach, and 1 and 2% glutaraldehyde to cause complete inactivation on
both high and low titers after 30 seconds (D‘Souza and Su, 2010). A different study
found 53 kDa chitosan to cause a 1.09, 2.09, and 2.83 log reductions on 107 titer and a
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2.12, 2.56, and 4.21 log reduction on a 105 titer after 3 hrs at 0.175, 0.35, and 0.7%
concentrations (Su et al., 2009).
More recently murine norovirus (MNV-1) has become cultivable in a lab and has
become another surrogate used for single stranded RNA viruses (Bae and Schwab, 2008;
Cannon et al., 2006). MNV-1 is another member of the Caliciviridae family and even
more genetically similar to the human norovirus because it is in the Norovirus genus.
Other similarities between MNV-1 and the human norovirus are the size (28-35 nm in
diameter), icosahedral shape, transmission route, and the symptoms after infection, which
includes diarrhea, fever, nausea, and abdominal pain (Green et al., 2001; Karst et al.,
2003). Since MNV-1 is the only norovirus that replicates in cell culture, it provides the
first chance to understand the relationship between mechanisms of norovirus replication
(Wobus et al., 2006). Although MNV-1 was originally isolated from brain tissue in mice,
this is not characteristic of the normal biology of the virus (Karst et al., 2003; Wobus et
al., 2006). Other scientist have been unable to isolate the pathogen from the brain of wild
type and immunocompromised lab mice that have been naturally infected or inoculated
through the peroral and intranasal routes with MNV-1 (Karst et al., 2003; Wobus et al.,
2006).
Over 2 hr MNV-1 had a 0.5-0.6 log reduction in a pH of 2- 4, even less of a
reduction in titer between pH 5-9, and a ~1.8 log reduction at pH 10 (Cannon et al.,
2006). This same study found that MNV-1 titer is reduced by 1 log at 56˚C, 63˚C
(consistent with low-temperature, long-time pasteurization) and 72˚C (consistent with
high-temperature, short-time pasteurization) in 6.7 min, 25 seconds, and 7 seconds,
respectively (Cannon et al., 2006). The effect of different molecular weights chitosan on
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MNV-1 showed that 53 kDa and 5 kDa chitosan reduced ~5 log or ~7 log PFU/ml viral
titers MNV-1 by less than 0.5 log PFU/ml (Su et al., 2009). Another study found that
washing inoculated onion bulbs and spinach leaves with water for 0.42 and 2 min,
respectively, caused a 0.4 and 1.0 log reduction, respectively (Baert et al., 2008). A 105
titer of MNV-1 was treated with PBS at pH 7.0, PBS at pH 2.6, orange juice at pH 3.8,
orange juice at pH 3.4, cranberry juice at pH 2.6, and cranberry juice at pH 7.0 to find a
0.07, 0.01, 0.03, 0.09, 2.06, and 1.64 log reductions, respectively (Su et al., 2010a). Su et
al. (2010c) found high intensity ultrasound at 20 kHz at < 21˚C to caused a 0.07 and
>3.79 log reduction after 30 min to FCV in PBS with a 106 and 104 titer, respectively. A
study by D‘Souza and Su (2010), found 5% TSP to be enough to completely inactivate a
high titer of MNV-1 after 30 seconds, while 1 and 2% glutaraldehyde, 10% bleach, and
70% ethanol caused a 2.44,6, 2.52, and 0.0 log reduction, respectively (D‘Souza and Su,
2010). The same study found 2% TSP, 1 and 2% glutaraldehyde, and 10% bleach to be
enough to completely a low titer of MNV-1 after 30 seconds, while 70% ethanol still had
no effect on the titer (D‘Souza and Su, 2010).
Bacteriophage MS2, which is commonly found in sewage and adopted to the
intestinal tract, is another enteric virus that is used as a surrogate for single stranded RNA
viruses as it is resistant to environmental conditions and used for environmental studies
(Dawson et al., 2005; Guan et al., 2006; Shin and Sobsey, 2003). As a member of the
Leviviridae family, MS2 has some similarities to human noroviruses, which include
being a positive sense, single stranded RNA viruses about 22-29 nm in size and
icosahedral in shape (Calender, 1988; Dawson et al., 2003; Toropova et al., 2008). As a
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bacteriophage, MS2 natural host is Gram negative bacteria, such as E. coli ATTC
15597B (Friedman et al., 2009).
Over 4 hrs MS2 demonstrates stability in a pH of 6.7, but has a 1.11 log reduction
at pH 3.9, which is the isoelectric point (Langlet et al. 2007), and a 3 log reduction in a
pH of 2.5 (Langlet et al. 2007). Other studies have found proanthocyanins and
polyphenols of cranberry juice and pomegranate juice to be the major reason for a titer
decrease of MS2 rather than the pH (Su et al., 2010a; Su et al., 2010b). A 105 titer of MS2
was treated with PBS at pH 7.0, PBS at pH 2.6, orange juice at pH 3.8, orange juice at pH
3.4, cranberry juice at pH 2.6, and cranberry juice at pH 7.0 to find a 0.00, 0.34, 0.13,
0.71, 1.14, and 0.39 log reductions, respectively (Su et al., 2010a). The effect of different
molecular weights chitosan on MS2 showed that 53 kDa chitosan reduced ~5 log PFU/ml
viral titers of bacteriophage MS2 by 1.70 log PFU/ml, which was more efficient than 5
kDa chitosan that had a 0.98 log PFU/ml reduction (Su et al., 2009).
D‘Souza et al. (2010) found that 1% trisodium phosphate (TSP), which is a
common household cleaner, with 30 s contact times decreased a high titer of MS2 by 4.5
logs PFU, while the 2% and 5% TSP caused complete inactivation of the high titer. The
same study found 10% bleach, 70% ethanol, and 1 and 2% glutaraldehyde to cause
complete inactivation, 0.06, 2.18, and 3.22 log PFU/ml reduction on a high titer after 30 s
(D‘Souza et al., 2010). Dawson et al. (2005) found 100 ppm chlorine for 5 min to cause a
0.7 log reduction of MS2 on lettuce. Another study found that 20 ppm chlorine for 10
min caused a greater than 1.8 log reduction on lettuce (Casteel et al., 2008). One study
found that 50 and 100 ppm caused a 1.9 and 2.7 log reduction, respectively, on lettuce
after two min (Allwood et al., 2004). Dawson et al. (2005) did a study on the ability of
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MS2 to survive on fresh iceberg lettuce, baton carrot, cabbage, spring onion, curly leaf
parsley, capsicum pepper, tomato, cucumber, raspberries, and strawberries, which found
that MS2 had less than a 1 log reduction after 50 days at 4 and 8°C. Allwood et al. (2003)
found a titer of 109 log PFU/ml MS2 in tap water to take 25.7, 18.7, and 2.7 days at 4, 25,
and 37˚C, respectively, to have a 1 log reduction. Another study found that high intensity
ultrasound completely inactivated a ~104 titer of MS2 in PBS after 10 min and caused a
4.62 log reduction on the high titer of 106 in PBS after 30 min (Su et al., 2010c).
Phi X174 is a member of the Microviridae family and a bacteriophage used as a
surrogate for single stranded DNA enteric viruses (Brentlinger et al., 2002). Although phi
X174 is different from the other surrogates because it is a positive sense, circular DNA
virus, it is about 30 nm in size, icosahedral in shape, and has about a 4.4-6.3 kb genome
(Bennett et al., 2008; Ilag et al., 1994; Suzuki et al., 1999; Wichman and Brown, 2010).
Phi X174 starts the infections process by attaching to a lipopolysaccharide on the host
cell surface (Bennett et al., 2008; Bernhardt et al., 2002). This virus can typically be
found in soil, seawater, sewage, and in the intestine of animals (Brentlinger et al. 2002).
Phi X174 has an isoelectric point of 6.6 (Helmi et al., 2008) and infects Gram negative
bacteria including E. coli, S. Typhimurium and Shigella sonnei.
A105 titer of phi X174 was treated with PBS at pH 7.0, PBS at pH 2.6, orange
juice at pH 3.8, orange juice at pH 3.4, cranberry juice at pH 2.6, and cranberry juice at
pH 7.0 to find a 0.00, 0.00, 0.37, 1.01, 1.79, and 0.93 log reductions, respectively (Su et
al., 2010). Another study found that at 55% relative humidity it takes 1.87 and 0.85 ppm
ozone to cause 90% inactivation after 13.8 and 18.4 s, respectively (Tseng and Li, 2006).
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Solomon et al. (2009) found phi X174 to be completely resistant to quaternary
ammonium compounds and very susceptible to oxidative disinfectants, such as virkon.
Therefore, these four viruses were selected to determine the effectiveness of
chitosan as an antiviral agent against single stranded RNA and DNA viruses. The
objective of this study was to determine the effect of different molecular weights and
concentrations of chitosans on these enteric viral surrogates FCV-F9, MNV-1, phi X174
and MS2.
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Abstract

Chitosan is known to have bactericidal and antifungal activity. Although human
noroviruses are the leading cause of nonbacterial gastroenteritis, information on chitosan
efficacy against food-borne viruses is very limited. The objective of this work was to
determine the effectiveness of chitosans of different molecular weight against the
cultivable human norovirus surrogates, feline calicivirus, FCV-F9, murine norovirus,
MNV-1, and bacteriophages, MS2 and phi X174. Five purified chitosans (53, 222, 307,
421, ~1,150kDa) were dissolved in water, 1% acetic acid, or aqueous HCl pH= 4.3,
sterilized by membrane filtration, and mixed with equal volume of virus suspension to
obtain a final concentration of 0.7% chitosan and ~5 log PFU/ml. Virus-chitosan
suspensions were incubated for 3 hr at 37°C. Untreated viruses in PBS, in PBS with
acetic acid, and in PBS with HCl pH=4.3 were tested as controls. Water-soluble chitosan
(53 kDa) reduced phi X174, MS2, FCV-F9 and MNV-1 titers by 0.59, 2.44, 3.36, and
0.34 log PFU/ml respectively. Chitosans in acetic acid decreased phi X174 by 1.19-1.29,
MS2 by 1.88-5.37, FCV-F9 by 2.27-2.94, and MNV-1 by 0.09-0.28 log, respectively.
Increasing the molecular weight of chitosan showed a greater effect on MS2, but for all
other surrogates it did not appear to play a role on the antiviral effect of chitosan. Overall,
chitosan treatments showed a greatest log reduction of MS2, followed by FCV-F9, phi
X174, and with no significant effect on MNV-1.

39

1. Introduction

Chitosan has shown vast potential as an antimicrobial additive. It is a cationic
polysaccharide composed of glucosamine and acetyl-glucosamine units bound by b(14) glycosidic bonds, and classified by its molecular weight (MW) and degree
acetylation (DA). Generally, MW of chitosan ranges between 50 – 1,000 kDa with DA
between 0 - 30%. Chitosan is not currently recognized as GRAS, but it has acquired EPA
approval to be used as a biopesticide (Docket No. EPA-HQ-OPP-2007-0566-0019).
Preparations with chitosan are presently applied in the fields for waste water management
as a chelator, in medicine as wound dressings, and in agriculture as fungicidal sprays
(Koide, 1998; Reddy et al., 2000; Shahidi et al., 1999). Chitosan has shown promise for
use in the food industry as an antimicrobial, antioxidant, clarifying agent, and as a
packaging material (Devlieghere et al., 2004; Shahidi et al., 1999; Xie et al., 2001). It has
proven microbiocidal activity against bacteria and fungi (Helander et al., 2001; Reddy et
al., 2000) and recent data indicate it may have antiviral effects as well (Su et al., 2009).
The molecular weight, degree of acetylation, and the concentration are the factors that
determine the antimicrobial efficiency of chitosan (Chirkov, 2002).
Although the mechanisms of chitosan antimicrobial action are not completely
understood, there are several hypothesized mechanisms based on the positive charge of
the NH3+ group below a pH of 6.3 (Liu et al., 2004). Chitosan is thought to control
bacterial growth by one or more mechanisms including leakage of intracellular material
by interacting with the negative charges of the outer cell surface, blocking nutrient
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transport to and from the cell by stacking onto the cell surface, and interfering with DNA
transcription (No et al., 2002; Rabea et al., 2003; Tharanathan and Kittur, 2003; Zheng
and Zhu, 2003). Applied to fungi and yeast, chitosan is thought to interact with DNA
causing the inhibition of RNA and protein synthesis, increase membrane permeability by
interacting with charged phospholipids or proteins in the cellular membrane, and reduce
growth due to chelation of Ca2+ and other essential minerals or accumulation in the cell
affecting the cell wall and hyphae growth (Durango et al., 2006; El Ghaouth et al., 1992;
Hadwiger and Loschke, 1981; Roller and Covill, 1999). The proposed antiviral
mechanisms include blocking viral replication, and neutralizing mother and daughter
phage particles by affecting a stage of reproduction or neutralizing the virulence
(Chirkov, 2002; Kochkina and Chirkov, 2000). In addition, it has been shown that
chitosan acts indirectly in plants by inducing defense mechanisms towards various plant
pathogens including bacteria, fungi, and viruses (Badawy and Rabea, 2009; Fajardo et al.,
1998; Liu et al., 2007).
Human noroviruses are enteric viruses that are considered as the leading cause of
foodborne non-bacterial gastroenteritis (Mead et al., 1999). They belong to the
Caliciviridae family and are single stranded, non-enveloped, positive sense RNA viruses
(Donaldson et al., 2008; Hyde et al., 2009) Human noroviruses are icosahedral in shape
and about 27-38 nm in size (Donaldson et al., 2008; Taube et al., 2010). They are thought
to infect host by binding to histo blood group antigens (HBGAs) or complex glycans on
red blood cells in the gut, to iniate cell entry replication (Donaldson et al., 2008; Perry
and Wobus, 2010). Only 10 -100 viral particles are thought to be capable of causing
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infection and they are highly resistant to environmental conditions (Cheesbrough et al.,
2000).
Since human noroviruses are currently not cultivable in a lab (Duizer et al., 2004),
cultivable surrogates, such as feline calicivirus, FCV-F9; murine norovirus, MNV-1; and
coliphage MS2, are used in infectivity assays. Feline calicivirus F9 (FCV-F9) has been
commonly used as a surrogate for human noroviruses because it also belongs to the same
Caliciviridae family as human noroviruses (Bidawid et al., 2000; D‘Souza et al., 2006).
Feline calicivirus differs from human noroviruses because it is a respiratory virus that is
more susceptible to environmental conditions, such as low pH, than human noroviruses
(Cannon et al., 2006; Duizer et al., 2004; Perry et al., 2009; Radford et al., 2007;). On the
other hand, the recently cultivable murine norovirus (MNV-1) is more resistant to
environmental conditions than FCV-F9, is shed in feces, and is therefore considered to a
better surrogate for human noroviruses by some researchers (Bae and Schwab, 2008;
Cannon et al., 2006; Su et al., 2009; Wobus et al., 2006). MS2 is a bacteriophage that is
used as a surrogate for RNA viruses in environmental studies because it is resistant to
environmental conditions (Dawson et al., 2005; Guan et al., 2006; Shin and Sobsey,
2003). MS2 is a member of the Leviviridae family, similar to human noroviruses in
being positive sense, single stranded RNA viruses that are about 22-29 nm in size with an
icosahedral shape (Dawson et al., 2003; Langlet et al., 2007; Toropova et al., 2008). Phi
X174 is a bacteriophage used as a surrogate for single stranded DNA enteric viruses. Phi
X174 is a member f the Microviridae family and is a positive sense, circular, singlestranded DNA bacteriophage, about 30 nm in size (Brentlinger et al., 2002; Ilag et al.,
1994; Suzuki et al., 1999). It has an icosahedral shape and infects it host by attaching to a
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lipopolysaccharide on the host cell surface (Bennett et al., 2008; Bernhardt et al., 2002).
Therefore, these four viruses were chosen to determine the effectiveness of chitosan as an
antiviral agent.
The objective of this study was to determine the effect of different molecular weight
chitosans on the infectivity of enteric virus surrogates FCV-F9, MNV-1, phi X174 and
MS2.

2. Materials and Methods

2.1. Viruses, hosts, and cell lines

Coliphage phi X174 and its host Escherichia coli CN-13 (both received as a gift
from Dr. Suresh Pillai of Texas A&M University, College Station, TX); Coliphage MS2
and host, E. coli B-15597 (both from ATCC, Manassas, VA); Feline Calicivirus F9
(FCV-F9) and cell line Crandell Reese Feline Kidney (CRFK) cells (both from ATCC,
Manassas, VA); Murine Norovirus-1 (MNV-1; graciously provided by Dr. Skip Virgin,
Washington University, St. Louis, MO) and host RAW 264.7 cells (from the collection of
University of Tennessee at Knoxville) were used in this study.

2.2. Virus Propagation

For phi X174 and MS2, hosts E. coli CN-13 and E. coli B-15597 respectively,
were transferred twice in a 3% trypticase soy broth containing 0.1% glucose, 20µg/ml
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CaCl2, and 10 µg/ml thiamine with an incubation period of 6 hr at 37°C. After the second
incubation, the viruses were added to their hosts for ~18 hr. The viruses were harvested
by centrifugation at 3,000 x g for 10 min and filtered through a 0.2 µm membrane filter.
Finally, 1 ml aliquots placed into vials and the viruses were stored frozen at -20°C until
use in the experiment. For MNV-1 and FCV-F9, host cells Raw 264.7 and CRFK,
respectively, were incubated at 37°C with 5% CO2. Both cell lines were grown in
Dulbecco‘s modified Eagle‘s medium (DMEM) with 1% penicillin-streptomycin and
heat inactivated 10% fetal bovine serum (FBS). CRFK and RAW 264.7 cells were
infected with FCV-F9 and MNV-1, respectively, and incubated at 37°C with 5% CO2
until 90% lysis or greater. The incubation time for FCV-F9 was ~24 hrs and for MNV-1
was ~4-6 days. After lyses, the viruses were harvested by freeze-thawing, once for FCVF9 and three times for MNV-1. The viruses were centrifuged at 5,000 x g for 10 min.
Finally, supernatants were filtered through a 0.2 µm membrane filters, 1 ml aliquots
placed into vials, and frozen at -80°C until use in the experiment.

2.3. Chitosan application for inactivation

Water-soluble chitosan (MW 53 kDa, DA 9.1%; EZ Life Science Co. Ltd., Seoul,
South Korea) dissolved in sterile deionized distilled water to obtain a concentration of
1.4%, was mixed with equal volume of virus suspension in PBS to obtain a final
concentration of ~5 log10 PFU/ml virus titer and a 0.7% concentration of chitosan, and
incubated for 3hr at 37°C. Each of four other chitosans (222kDa, 32.5%DA, as
determined in our lab, Primex, Iceland; 307kDa, 20.2%DA, as determined in our lab,
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Primex, Iceland; 421kDa, 30.3%DA, as determined in our lab, Primex, Iceland; high
molecular weight, max 25%DA with an estimated MW of ~1,150kDa, Aldrich, St. Louis,
MO) was dissolved in 1% acetic acid and sterile deionized distilled water to form a
chitosan concentration of 1.4%. Chitosan solutions were mixed with equal volume of
virus suspension in PBS to reach a mixture of ~5 log10 PFU/ml virus titer and 0.7%
chitosan in 0.5% acetic acid, and incubated for 3hrat 37°C. Five controls were applied:
(a) ―3 hr‖ - a 3 hr incubation virus control (~5 log10 PFU/ml in PBS), (b) ―AcAc4.5‖ - a
virus control (~5 log10 PFU/ml in PBS) with acetic acid (~0.15%) to have pH similar to
the pH of 222-1,150 kDa chitosan and virus mixture, (c) ―AcAc5.6‖ - a virus control (~5
log10 PFU/ml in PBS) with acetic acid (~0.0625%) to have pH similar to the pH of 53
kDa chitosan and virus mixture, (d) ―HCl4.5‖ - a virus control (~5 log10 PFU/ml in PBS)
with hydrochloric acid (~0.010125%) to have pH similar to the pH of 222-1,150 kDa
chitosan and virus mixture and (e) ―HCl5.6‖ - a virus control (~5 log10 PFU/ml in PBS)
with hydrochloric acid (~0.0095%) to have pH similar to the pH of 53 kDa chitosan and
virus mixture. To eliminate effect of acid used as a solvent, 222 - ~1,150 kDa chitosans
were tested in acetic acid and in aqueous HCl at pH values similar to the pH of the
chitosan in acetic acid samples (pH 4.15 – 4.3). All treatments were done in duplicate and
replicated at least twice.

2.4. Plaque Assay Infections

The method of Bae and Schwab (2008) and Su et al. (2009) was followed for the
MS2 and phi X174 plaque assays with the exception that 0.7 ml of serially diluted treated
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or untreated phage MS2 was mixed with 0.3 ml of 5-6 hr E. coli B-15597 in 8 ml of 0.6
% tryptic soy top agar, and poured on tryptic soy agar (TSA) plates containing 0.5%
NaCl. For phi X174, 0.7 ml of serially diluted treated or untreated phage phi X174 was
mixed with 0.25 ml of 5-6 hr E. coli CN-13 host with 8 ml of 0.6 % trptic soy top agar,
and poured on TSA plates. For both viruses, plates were incubated at 37oC overnight and
plaques were counted.
Plaque assays for MNV-1 were done similarly to the procedures described by
Wobus et al. (2004) and Su et al. (2009). After flasks containing RAW 264.7 cells were
confluent, 2 ml of cells were added to each well in a 6-well plates and incubated until
~90% confluent. Treated and untreated MNV-1 was serially diluted tenfold in DMEMF12 containing 10% FBS. After the media of each 6-well plate was aspirated, 0.5 ml of
each virus dilution (treated and untreated controls) was inoculated and cells were
incubated at 37°C under 5% CO2 for 2.5 hr for infection. Again, the media of the 6-well
plates was aspirated and the cells were overlaid with 2 ml of DMEM F-12 containing
0.75% agarose, 10% FBS and 1% penicillin-streptomycin. The 6-well plates were
allowed to solidify and then incubated for 72 hr at 37oC under CO2. Finally, the plates
were overlaid with a staining media that contained the same ingredients as the first
overlay media plus 0.02% neutral red, allowed to solidify, incubated for 3-5 hrs at 37°C
under 5% CO2 and plaques were counted.
Plaque assays for FCV-F9 were done according to the procedure of D‘Souza et al.
(2006) and Su et al. (2009). CRFK cells were grown in flask at 37°C under 5% CO2 until
confluent. CRFK cells were added to 6-well plates (2 ml) and incubated until ~90%
confluent. Treated and untreated FCV-F9 were serially diluted tenfold in DMEM F-12
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containing 2% FBS. After the wells in the plate were aspirated, they were inoculated with
0.5 ml of the virus dilutions (treated and untreated controls) and incubated for 2.5 ml at
37°C under 5% CO2. The media of the 6-well plates were aspirated and then overlaid
with DMEM F-12 containing 0.75% agarose, 2% FBS and 1% penicillin-streptomycin.
The plates were incubated for 48 hrs and overlaid with overlay media that contained
0.01% neutral red along with the other ingredients of the previous overlay. The plates are
allowed to solidify, incubated for no longer than 24 hrs under 5% CO2, and plaques were
counted.

2.5. Statistical analysis

ANOVA and Tukey‘s test were determined on a completely randomized design
with sampling using SAS software (version 9.2, SAS Institute, Cary, NC, USA) on data
from at least two replications with duplicates.

3.

Results and Discussion

3.1 Acetic acid and HCl effect on viruses

The pH of the chitosan solutions did cause a significant reduction on most of the
tested surrogates at 37˚C for 3 hr. Phi X174 exhibited a 0.70-0.69 and 0.46-0.47 log
PFU/ml reduction at pH 4.5 and 5.6, respectively (Table 1). Our results showed a 0.891.02 and 0.58-0.64 log PFU/ml reduction at pH 4.5 and 5.6, respectively, for MS2 (Table
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1). In our study FCV-F9 had a 0.91-0.95 and 0.38-0.47 log PFU/ml reduction at pH 4.5
and 5.6, respectively (Table 1). For MNV-1, we found that 0.19-0.23 and 0.30-0.14 log
PFU/ml reduction at pH 4.5 and 5.6, respectively (Table 1).
Controls with acetic acid and hydrochloric acid alone were run to confirm that
reduction in the virus titer was due to the chitosan rather than the pH and/or type of acid
in the chitosan solutions. Except for 222 kDa against MS2 and FCV-F9, the type of acid
did not have an effect on the antiviral activity. Technical difficulties encountered during
preparation of high viscosity chitosans at high concentration could potentially account for
the differences in viral recovery between replicates and acetic acid and hydrochloric acid.
Acetic acid is the typical acid used with chitosan and is known to have antibacterial
activity. Thus, hydrochloric acid was used at the same pH as acetic acid samples. Acetic
acid has been found to be effective in inactivating microorganisms that include Listeria
monocytogenes, Enterobacter sakazakii, and Salmonella enterica serovar Typhimurium
(Alvarez-Ordonez et al., 2009; Back et al., 2009; Vasseur et al., 1999). However,
hydrochloric acid has been shown to have limited antibacterial activity compared to
acetic acid on Listeria monocytogenes, Enterobacter sakazakii, and Listeria innocua
(Back et al., 2009; Conner et al., 1989; Ita and Hutkins, 1991; Miller et al., 2009).
Hydrochloric acid has less antibacterial activity because it has a higher dissociation
constant than acetic acid. Undissociated acetic acid is able to enter the bacteria cell,
dissociate and decrease the pH inside the cell, and cause the cell to use up its energy
trying to remove the hydrogen ions.On the other hand, HCl is dissociated at all practical
pH (pH >1), and thus unable to easily pass the cell membrane.Our results had similar
reduction trends to previous studies showing the effect of pH on MS2. Langet et al.
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(2007) found a 1.11 log PFU reduction and no reduction on MS2 at pH 3.9 and 6.7,
respectively. Our results for FCV-F9 were slightly lower than the results found in Cannon
et al.(2006), who showed ~2.0, ~1.0, ~1.5 log reduction at pH 4, 5 and 6, respectively,
after 30 min with citrate or phosphate buffer. A study by Cannon et al. (2006) found
~0.50, ~0.50, and ~0.10 log reduction at pH 4, 5, and 6, respectively, of MNV-1. The
study by Cannon et al. (2006) tested 30 min and 2 hr, but chose to only present the 30
min results because a statistical difference was not seen. Differences in the inactivation
trends at the pH values between 4-6 could also be due to the different acids used in
experiments. Citric acid and acetic acid have been shown to have similar antibacterial
effects against E. coli, S. Typhimurium, Y. enterocolitica, and L. monocytogenes, which
could be due to citric acid acting as a chelator (Akbas and Olmez, 2007; Dickson, 1992;
Fernandez Escartin et al., 1989; Karapinar and Gonul, 1992). It could be possible in this
case, that citric acid is more effective against these viruses than acetic acid.

3.2 Effect of Chitosan of phi X174
Chitosan with MW greater than 53 kDa reduced the recovery of phi X174
compared to the 3 hr control, but not to the pH controls (Table 1). Although the reduction
was statistically significant (P<0.05), the greatest reduction was 1.29 log PFU/ml, which
was achieved with ~1,150 kDa in acetic acid, out of which 0.70 log PFU/ml can be
attributed to the effect of pH. The type of acid did not appear to have any effect on the
virus recovery neither in controls nor in samples, but the pH of the solutions did appear to
be a factor in the reduction of the virus. Chitosan with the smallest molecular weight
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tested (53kDa) had no effect on phi X174 recovery (0.59 log PFU/ml), while all other
chitosans resulted in titer reduction of 1.06-1.29 log PFU/ml.

3.3 Effect of Chitosan on MS2

Chitosan, in general, had the largest effect on MS2, followed by FCV-F9 and phi
X174, and had minimal to no effect on MNV-1 (Table 1). The recovery of MS2
compared to the controls was significantly reduced by all five tested chitosans (Table 1).
Chitosans with MWs from 53 to 307 kDa had similar effects on MS2, and further
increase in MW resulted in further reduction of MS2 recovery. Both acetic (pH 5.6) and
hydrochloric acid (pH4.5) controls caused less than a log PFU/ml reduction (0.61 and
0.96, respectively). Chitosan of 222 kDa appeared to be more effective in HCl than in
acetic acid, resulting in 3.27 and 2.28 log PFU/ml reduction, respectively. Chitosan with
the highest tested molecular weight (~1,150 kDa) caused the greatest reduction in MS2,
resulting in complete inactivation. For MS2, increase in molecular weight of chitosan was
directly proportional to the reduction in MS2 titers.

3.4 Effect of Chitosan on FCV-F9

FCV-F9 was similarly affected by both acids at both pH values, which was about
0.43 and 0.93 log PFU/ml reduction at pH 5.6 and 4.5, respectively (Table 1). Chitosan of
all five molecular weights did cause significant decreases in the recovery of FCV-F9
compared to the controls. Contrary to effects on MS2, there was no indication that
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molecular weight of chitosan has any effect on its antiviral activity against FCV-F9.
Interestingly however, 222 kDa chitosan in HCl was more efficient than the same
chitosan in acetic acid against both MS2 and FCV-F9.

3.5 Effect of Chitosan on MNV-1

The recovery of MNV-1 was not affected by any of the five tested chitosans
(Table 1). In addition, neither acetic nor hydrochloric acid at pH 4.5 or 5.6 had any effect
on the virus infectivity. The reduction values ranged between 0.09 and 0.34 logs PFU/ml,
for 307 kDa in acetic acid and 53 kDa chitosan, respectively. Longer contact time
between chitosan and virus or higher concentrations of chitosan may be needed to
inactivate MNV-1.

3.6 Discussion of chitosan as an antiviral agent

The proposed direct antiviral mechanisms of chitosan are similar to the antifungal
and antibacterial mechanisms. The hypotheses are that chitosan causes structural damage
to the virus causing inactivation (Kochkina et al., 2000), interacts with the negative
charge of the viral capsids (Kochkina et al., 2000; Su et al., 2009), inhibits phage
infection (Kochkina et al., 1995), or interferes with a step in the replication process
(Chirkov, 2002; Kochkina et al., 2000). Chitosan has been shown to exhibit indirect
antiviral activity by penetrating the plant cell to induce resistance (Kulikov et al., 2006).
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However, there is not much literature on the effect of chitosan on foodborne viruses (Su
et al., 2009).
Molecular weight is thought to play an important role in the antibacterial effect of
chitosan. Studies have found the antibacterial activity to increase against Gram negative
(Escherichia coli) bacteria as the MW decreases (Li et al., 2009; Zheng and Zhu, 2003).
Also, Zheng and Zhu (2003) studied the effect of different molecular weights on Gram
positive bacteria (Staphylococcus aureus) and found that as molecular weight increased
from less than 5kDa to 305 kDa the antibacterial activity increased. Similarly, chitosan
between 28 – 1671 kDa inhibited growth of both Gram negative (E. coli, Pseudomonas
fluorescens, Salmonella Typhimurium, and Vibrio parahaemolyticus) and Gram positive
(Listeria monocytogenes, Bacillus cereus, S. aureus, Lactobacillus plantarum,
Lactobacillus brevis, and Lactobacillus bulgaricus) bacteria better than chitosan
oligomers between 1-22 kDa (Gerasimenko et al., 2004; Zivanovic et al., 2004).
Effect of molecular weight of chitosan against viruses has mostly been studied
indirectly, as chitosan-induced plant resistance to viral attack. Thus, Chirkov et al. (1998)
reported that as the molecular weight of chitosan increased from 3-50 kDa, bean plants
resistance to bean mild mosaic virus increased, but Kulikov et al. (2006) found that bean
plants resistance to bean mild mosaic virus decreased as the MW of chitosan increased
from 1.2-40.4 kDa. The only recently published study on the direct effects of chitosan of
different molecular weights on human noroviruses surrogates showed that 53 kDa
chitosan reduced ~5 log PFU/ml viral titers of bacteriophage MS2 and FCV-F9 (1.70 and
4.21 log PFU/ml, respectively) more efficiently than 5 kDa chitosan (0.98 and 1.41 log
PFU/ml, respectively) (Su et al. 2009). Between Su et al. (2009) and this study, 0.7%
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chitosan ranging from 5kDa to ~1,150 kDa is found to be ineffective at inactivating
MNV-1 after 3hr contact.
Several chemical methods and additives have been studied to determine their
effect on these enteric viral surrogates The titer of MS2 was completely inactivated (6.98
log PFU/ml) by 5% TSP (trisodium phosphate) and 10% bleach, while a 4.90, 6.03, 2.15,
and 3.74 PFU/ml log reduction was seen for 1 and 2% TSP and 1 and 2% glutaraldehyde,
respectively after 1 min contact time (D‘Souza and Su, 2010). In our study, after 3 hr
incubation, chitosan between 53-~1,150 kDa chitosan caused between a 1.85-5.37
(complete inactivation) log PFU/ml reduction. Similarly, a titer of ~105 log FCV-F9 was
found to be completely inactivated by 1% TSP 1% glutaraldehyde, and 10% bleach using
a 1 minute of contact time (D‘Souza and Su, 2010) while we showed thtat chitosan
between 53 and ~1,150 kDa decreased the titer of ~105 FCV-F9 between 2.70-4.31 log
PFU/ml after 3 hr.
A titer of ~107 log PFU/ml MNV-1 was completely inactivated by 5% TSP,
nearly completely inactivated by 2% glutaraldehyde (6 log reduction), and reduced by ~3
log PFU/ml by 1% glutaraldehyde and 10% bleach while 1 and 2% TSP had a ~1 log
reduction or less. Liquid hydrogen peroxide at 2.1% was found to cause a ~3 and ~4 log
PFU/ml reduction of MNV-1 and phi X174, respectively after 10 min (Li et al., 2011).
The present study shown that chitosan between 53-~1,150 kDa reduced ~105 phi X174 by
0.59-1.29 log PFU/ ml and did not significantly decrease the titer of ~105 MNV-1 at any
of the tested MWs. Chitosan used solely to clean contaminated products does not appear
to be as sufficient antiviral agent compared to these other chemicals. However, chitosan
does still show potential as a natural antiviral while being used for other potential
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applications in the food industry where antibacterial and antifungal properties are needed
as well as antioxidant, chelating, clarifying, or thickening properties, such as pre- or postharvest sprays, water purification, additives, or packaging.
Bacteriophage MS2 showed the most vulnerability to chitosan. It showed similar
susceptibility to chitosan from 53 kDa- 307 kDa, with an increase in antiviral activity as
the molecular weight increased to ~1,150 kDa. There is a larger gap in MW range
between 421 kDa and ~1,150 kDa compared to 53 kDa - 307kDa, which could be the
reason for the observed increase in the antiviral activity with ~1,150kDa for MS2. For
FCV-F9 and phi X174, chitosan showed statistically similar effects over the entire
chitosan MW range used in the experiment and did not show a trend between the
molecular weight and antiviral effect. MNV-1 showed no significant reduction in titers
due to chitosan treatment. Although, a clear trend of increasing antiviral activity with
increasing molecular weight cannot be seen for all the four viruses tested, lower
molecular weight chitosan does not appear to be more effective than the higher molecular
weight chitosan on any of the tested viruses. The method of viral inactivation by chitosan
needs to be examined to help explain the inactivation of viruses seen in this study.

4. Conclusions

Chitosan, at a concentration of 0.7%, was the most effective against MS2,
followed by FCV-F9 and phi X174, while ineffective against MNV-1. Reduction of MS2
infectivity by chitosan increased as molecular weight of chitosan increased, with high
molecular chitosan (~1,150 kDa) being able to completely reduce the virus titer.
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Susceptibility of FCV-F9 and phi X174 was not MW-dependent. In addition, the pH of
the medium had more effect on the infectivity of the tested viruses than the type of the
acid used to lower th pH, except in the case with 222 kDa chitosan in acetic and
hydrochloric acid against MS2 and FCV-F9,. This data indicates that chitosan as an
antiviral agent has potential application in the food industry, which could be in packaging
material, coatings, or as pre- or post-harvest sprays on crops.
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Table 1. Effect of 0.7% chitosan in water, acetic acid (AcAc) or hydrochloric acid (HCl)
on the reduction of phi X174 phage, MS2 phage, FCV-F9, and MNV-1 using titers of ~5
log PFU/ml. Different letters when compared within each column denote significant
differences (P<0.05).

Reduction (log PFU/ml)
Treatment
Phi X174

4.5 pH

FCV-F9

MNV-1

0.00C ± 0.00

0.00F

± 0.00

0.00D

± 0.00

0.00A

±

0.00

AcAc cont.

0.47BC ± 0.08

0.64E

± 0.09

0.47D

± 0.04

0.03A

±

0.04

HCl cont.

0.46BC ± 0.07

0.58EF

± 0.11

0.38D

± 0.04

0.14A

±

0.04

53 kDa

0.59ABC ± 0.02

2.44D

± 0.14

3.84AB

± 0.68

0.34A

±

0.36

AcAc cont.

0.70ABC ± 0.07

1.02E

± 0.10

0.95D

± 0.08

0.19A

±

0.08

HCl cont.

0.69ABC ± 0.14

0.89E

± 0.06

0.91D

± 0.07

0.23A

±

0.04

AcAc 222 kDa

1.19AB ± 0.31

2.28D

± 0.25

2.49C

± 0.57

0.28A

±

0.28

HCl 222 kDa

1.08AB ± 0.42

3.27C

± 0.40

4.31A

± 0.41

0.13A

±

0.11

AcAc 307 kDa

1.20AB ± 0.28

1.88D

± 0.19

2.27C

± 0.43

0.09A

±

0.08

HCl 307 kDa

1.15AB ± 0.28

1.85D

± 0.42

3.12ABC

± 0.15

0.14A

±

0.12

AcAc 421 kDa

1.28A ± 0.27

3.90B

± 0.24

2.94BC

± 0.24

0.15A

±

0.09

HCl 421 kDa

1.29A ± 0.25

3.56BC

± 0.35

2.84BC

± 0.10

0.18A

±

0.07

1.29A ± 0.27

5.37A

± 0.00

2.70BC

± 0.08

0.20A

±

0.16

1.06AB ± 0.15

5.37A

± 0.00

3.17ABC

± 1.02

0.27A

±

0.22

3 hr control

5.6 pH

MS2

AcAc ~1,150
kDa
HCl ~1,150 kDa
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Abstract

Enteric viruses are a major problem in the food industry, especially the human
noroviruses, which are the leading cause of nonbacterial gastroenteritis. Chitosan has
been shown to be effective against some enteric viral surrogates, but a more
comprehensive study is needed. The objective of this work was to determine the effect of
chitosan concentration on the cultivable enteric viral surrogates, feline calicivirus, FCVF9, murine norovirus, MNV-1, and bacteriophages, MS2 and phiX174. Two chitosans
(53 and 222 kDa) were dissolved in water and 1% acetic acid, sterilized by membrane
filtration, mixed virus suspension to obtain a final concentration ~5 log PFU/ml virus titer
and 0.7%, 1.0%, 1.25, and 1.5% chitosan, and incubated for 3 hr at 37°C. Untreated
viruses in PBS were tested as controls. The 53 kDa chitosan with tested concentrations
reduced phi X174, MS2, FCV-F9 and MNV-1 titers by 0.68-0.94, 2.61-2.80, 2.64-2.91,
and 0.10-0.35 log PFU/ml, respectively, while reduction by 222 kDa chitosan was 0.510.75, 2.63-5.16, 2.22-2.41, and 0.82-0.95 log PFU/ml, respectively. There was no
significant improvement in reduction of phi X174, FCV-F9, and MNV-1 titers with
increasing concentration of both chitosans in the tested range (0.7-1.5%). However, 1%
222kDa chitosan in acetic acid (pH 4.5) caused complete reduction (5.16 log) of MS2,
while the reduction was only 2.63 when applied at 0.7%. Overall, chitosan treatments
showed the greatest log reduction of MS2, followed by FCV-F9, phi X174, and MNV-1.
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1. Introduction

The antimicrobial properties of chitosan against bacteria and fungi have been
explored extensively, but there is still much to learn about viral inactivation. Chitosan,
derived from chitin through deacetylation, is a positively charged polysaccharide
composed of glucosamine and acetyl-glucosamine. It is classified by its molecular weight
(MW), which mostly ranges between 50 to 1000 kDa, and degree deacetylation (DDA),
which ranges between70-100%. Concerns of chitosan being an allergen have kept it off
the GRAS (generally recognized as safe) list. However, studies have shown that chitosan
should not be considered as an allergen because of the harsh acid and base steps in the
extraction and deacetylation process, which remove proteins, fats, and any other
impurities that may be present (Muzzarelli, 2010). Even though it is not GRAS, it has
acquired EPA approval for use in biopesticides (Docket No. EPA-HQ-OPP-2007-05660019). There are numerous potential applications for chitosan in agriculture as an
antioxidant, antimicrobial, clarifying agent, and as a packaging material (Devlieghere et
al., 2004; Shahidi et al., 1999; Xie et al., 2001).
Chitosan has shown to have antimicrobial activity against bacteria, fungi, and
yeast (Helander et al., 2001; Reddy et al., 2000; Sudarshan et al., 1992) and recent studies
indicate it may have antiviral activity as well (Chirkov, 2002; Su et al., 2009). The MW,
DDA, and the concentration are the features of chitosan associated with the antimicrobial
activity (Chirkov, 2002). Although the mechanisms of action are not completely
understood, there are several hypothesized mechanisms related to chitosans positive
charge below pH 6.3 (Liu et al., 2004). It is proposed that chitosan induces leakage of
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intracellular material and alters transport of materials through electrostatic interactions
with negatively charged components of the outer cell, controls growth through chelation
of essential minerals, interferes with DNA transcription of microorganisms, or indirectly
induce defense mechanisms of plants (Badawy and Rabea, 2009; Durango et al., 2006; El
Ghaouth et al., 1992; Hadwiger and Loschke, 1981; Stossel and Leuba, 1986; Li et al.,
2010; Rabea et al., 2003; Roller and Covill, 1999; Tharanathan and Kittur, 2003; Zheng
and Zhu, 2003).
Foodborne viruses are recognized as one of the major causes of foodborne illness
and death. Viruses are responsible for 5.5 of the 9.4 million illnesses (59%), 27% of the
55,961 hospitalizations, and 12% of the 1,351 deaths related to food contamination
(Scallan et al., 2011). Of the viruses studied, the human norovirus was the leading cause
for all three categories. Human noroviruses are enteric viruses that are considered to be
the cause of more than 90% foodborne non-bacterial gastroenteritis or about 5.5 million
reported cases annually (Mead et al., 1999; Patel et al., 2008; Scallan et al., 2011).
However, this number may be underestimated due to milder cases not reported. As a
member of the Caliciviridae family, human noroviruses have single stranded positive
sense RNA genomes ~7.5kb in size (Jiang and Estes, 1990; Perry and Wobus, 2010)
These viruses are non enveloped, have an isocahedral shape being about 27-38 nm in
size, and only require about 10-100 particles to cause infection (Bok et al., 2009;
Cheesbrough et al., 2000; Hyde et al., 2009; Taube et al., 2010). Human noroviruses have
been shown to be sensitive to heat treatments and chlorine at concentrations >2mg/l, but
have been shown to be less susceptible to pH (Cliver et al., 2002; Koopmans et al. 2002).
. The major cause of contaminated food and water occurs through the fecal-oral route
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through person to food contact, person to person contact, person to environmental
surface, contaminated vomit, or aersolization (Greening, 2006; Patel et al., 2009; Sair et
al., 2002). The major foods at risk are handled and ready to eat foods that do not undergo
further cooking conditions, which include fresh produce, juices, shellfish, salads, and
boxed lunches (Grove et al., 2006; Sair et al., 2002)
Since there is no lab host cell culture system for human norovirus propagation
currently, cultivable surrogates, such as feline calicivirus (FCV-F9), murine norovirus
(MNV-1), and coliphage MS2, are used in infectivity assays (Doultree et al., 1999;
Duizer et al., 2004). As a member of the Caliciviridae family, FCV-F9 is used as a
surrogate due to its genetic similarities (Bidawid et al., 2000; D‘Souza et al., 2006).
However, it differs from the human noroviruses because it is transmitted through the
nasal, oral, or conjunctival routes causing a respiratory infection and is more susceptible
to low pH than enteric viruses (Cannon et al., 2006; Duizer et al., 2004; Perry et al.,
2009; Radford et al., 2007). As a member of the same Calicivirdae family and under the
Norovirus genus, MNV-1is considered a better surrogate system to study the biology and
pathogenesis of the human noroviruses by some researchers because it is more resistant
to environmental conditions than FCV-F9 and is an enteric virus with similar clinical
symptoms (Cannon et al., 2006; Green et al., 2001; Karst et al., 2003; Wobus et al.,
2006). Bacteriophage MS2 is a member of the Leviviridae family and is commonly used
as a surrogate for enteric RNA viruses in water contamination studies because it is
adapted to the intestinal tract, (Dawson et al., 2005). It has similarities to human
noroviruses, which include being positive sense, single stranded RNA virus about 22-29
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nm in size with an isocahedral shape (Calender, 1988; Dawson et al., 2005; Guan et al.,
2006; Langlet et al., 2007; Shin and Sobsey, 2003; Toropova et al., 2008). Phi X174,
which is commonly used as an indicator for fecal contamination, was used a surrogate for
single stranded DNA enteric viruses (Charles et al., 2009). As a member of the
Microviridae family, phi X174 is a positive sense, circular, single-stranded DNA
bacteriophage, about 30 nm in size with an isocahedral shape (Bennett et al., 2008;
Bernhardt et al., 2002; Brentlinger et al., 2002; Ilag et al., 1994; Suzuki et al., 1999).
The objective of this study was to determine the effect chitosan concentration on the
enteric virus surrogates FCV-F9, MNV-1, phi X174 and MS2.

2. Materials and Methods

2.1. Viruses, hosts, and cell lines

Coliphage phi X174 and its host Escherichia coli CN-13 (both received as a gift
from Dr. Suresh Pillai of Texas A&M University, College Station, TX); Coliphage MS2
and host, E. coli B-15597 (both from ATCC, Manassas, VA); Feline Calicivirus F9
(FCV-F9) and cell line Crandell Reese Feline Kidney (CRFK) cells (both from ATCC,
Manassas, VA); Murine Norovirus-1 (MNV-1; graciously provided by Dr. Skip Virgin,
Washington University, St. Louis, MO) and host RAW 264.7 cells (from the collection of
University of Tennessee at Knoxville) were used in this study.

2.2. Virus Propagation
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For phi X174 and MS2, hosts E. coli CN-13 and E. coli B-15597 respectively,
were transferred twice in 3% trypticase soy broth containing 0.1% glucose, 20µg/ml
CaCl2, and 10 µg/ml thiamine with an incubation period of 6 hr at 37°C. Following the
second incubation, the viruses were added to their hosts for ~18 hr. The viruses were
collected by centrifugation at 3,000 x g for 10 min and the supernatant was filtered
through a 0.2 µm membrane filter. Lastly, 1 ml aliquots were placed into vials to be
stored frozen at -80°C until use in the experiment. For MNV-1and FCV-F9, host cells
Raw 264.7 and CRFK, respectively, were incubated at 37°C under 5% CO2. Both cell
lines were grown in Dulbecco‘s modified Eagle‘s medium (DMEM) with 1% penicillinstreptomycin and 10% heat inactivated fetal bovine serum (FBS). RAW 264.7 and CRFK
cells were infected with MNV-1 and FCV-F9, respectively, and incubated at 37°C under
5% CO2 until at least 90% lysis. The incubation time for MNV-1 was ~4-6 days and
FCV-F9 was ~24 hr. After lyses, the viruses were harvested by freeze-thawing, three
times for MNV-1 and once for FCV-F9. Next, the viruses were centrifuged at 5,000 x g
for 10 min. Lastly, supernatants were filtered through a 0.2 µm membrane filters, 1 ml
aliquots placed into vials, and frozen at -80°C until use in the experiment.

2.3. Chitosan application for viral inactivation

Water-soluble chitosan (MW 53 kDa, DA 9.1%; EZ Life Science Co. Ltd., Seoul,
South Korea) dissolved in sterile deionized distilled water at a concentration of 1.4%,
2.0%, 2.5%, and 3.0% was mixed with equal volume of virus suspension in PBS to obtain
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the final concentrations of ~5 log10 PFU/ml virus titer and 0.7%, 1%, 1.25%, and 1.5%
chitosan and incubated for 3hrat 37°C. Chitosan of 222kDa and 32.5%DA (as determined
in our lab, Primex, Iceland) was dissolved in 1% acetic acid and sterile deionized distilled
water to form a chitosan concentration of 1.4%, 2.0%, 2.5%, and 3.0%. Chitosan
solutions were mixed with equal volume virus suspension in PBS to reach a mixture with
the final concentrations of ~5 log10 PFU/ml virus titer and of 0.7%, 1.0%, 1.25, and 1.5%
chitosan in 0.5% acetic acid, and incubated for 3 hr at 37°C. Three controls were applied:
(a) ―3 hr‖ - a 3 hr incubation virus control (~5 log10 PFU/ml in PBS), (b) ―AcAc4.5‖ - a
virus control (~5 log10 PFU/ml in PBS) with acetic acid (~0.15%) to have pH similar to
the pH of 222 kDa chitosan and virus mixture, (c) ―AcAc5.6‖ - a virus control (~5 log10
PFU/ml in PBS) with acetic acid (~0.0625%) to have pH similar to the pH of 53 kDa
chitosan and virus mixture. All treatments were done in duplicate and replicated at least
twice.

2.4. Plaque Assay Infections

The technique of Bae and Schwab (2008) and Sue et al. (2009) was followed for
MS2 and phi X174 plaque assays with exception that 0.7 ml of serially diluted treated
and untreated bacteriophage MS2 was mixed with 0.30 ml of 5-6 hr E. coli B-15597 in 8
ml of 0.6 % top agar, and poured on tryptic soy agar (TSA) plates containing 0.5% NaCl.
For phi X174, 0.7 ml of serially diluted treated and untreated phage phi X174 was mixed
with 0.25 ml of 5-6 hr E. coli CN-13 host with 8 ml of 0.6 % top agar, and poured on
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tryptic soy agar (TSA) plates. For both viruses, plates were incubated at 37oC overnight
before plaques were counted.
Plaque assays for MNV-1 were done similarly to Wobus et al. (2004) and Su et al.
(2009). After confluent RAW 264.7 cells were grown in flasks, 2.0 ml of cells were
added to each well in 6-well plates and incubated until ~90% confluent. Treated and
untreated MNV-1 was serially diluted tenfold in DMEM-F12 containing 10% FBS. After
the media of each 6-well plate was aspirated, it was inoculated with 0.50 ml of each virus
dilution (treated and untreated controls) and incubated at 37°C under 5% CO2 for 2.5 hrs.
Again, the media of the 6-well plates was aspirated and the cells were overlaid with 2 ml
of DMEM F-12 containing 0.75% agarose, 10% FBS and 1% penicillin-streptomycin.
The 6-well plates were allowed to solidify and then incubated for 72 hrs before staining
media, which contained the same ingredients as the first overlay media plus 0.02%
neutral red, was added and allowed to solidify. Finally, the plates were incubated for 3-5
hrs at 37°C under 5% CO2 before plaques were counted.
Plaque assays for FCV-F9 were done according to the procedure of D‘Souza et al.
(2006) and Su et al. (2009). CRFK cells were grown in flask at 37°C under 5% CO2 until
confluent. CRFK cells were added to 6-well plates (2 ml) and incubated until ~90%
confluent. Treated and untreated FCV-F9 were serially diluted tenfold in DMEM F-12
containing 2% FBS. After the wells in the plate were aspirated, they were inoculated with
0.5 ml of the virus dilutions (treated and untreated controls) and incubated for 2.5 hrs at
37°C under 5% CO2. The media of the 6-well plates were aspirated and then overlaid
with DMEM F-12 containing 0.75% agarose, 2% FBS and 1% penicillin-streptomycin.
The plates were incubated for 48 hrs and overlaid with another overlay media that
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contained 0.01% neutral red along with the other ingredients of the previous overlay. The
plates solidify before being incubated for no longer than 24 hrs under 5% CO2. Finally,
the plaques were counted.

2.5. Statistical analysis

ANOVA and Tukey‘s test were determined on a completely randomized design
with sampling using SAS software (version 9.2, SAS Institute, Cary, NC, USA) on the
data from at least two replications with duplicates.

3. Results and Discussion

3.1 Effect of Chitosan on phi X174

Only concentrations of 1.25% and 1.5% of 53 kDa chitosan significantly reduced
phi X174 compared to the 3 hr control, and only 1.5% 53 kDa was significantly different
from the pH control (pH 5.6) by 0.47 log PFU/ml (Table 1). All other concentrations of
53 kDa and 222 kDa chitosan did not cause significant reduction of phi X174 (Table 1).
Although the reduction was statistically significant (P<0.05) from the 3 hr control, the
reduction of 1.5% 53 kDa chitosan was only 0.94 log PFU/ml. For phi X174, increasing
the concentration shows little promise at reducing the recovery.

3.2 Effect of Chitosan on MS2

77

The greatest effect of chitosan was seen on MS2 compared to the other surrogates,
which was the trend seen by increasing the MW of chitosan in Chapter III. All
concentrations of 53kDa and 222 kDa chitosan caused significant reduction of MS2.
Similar reductions of MS2 were found for both chitosan at 0.7% compared to our
previous work (Chapter III) on the effect of chitosan molecular weight. The recovery of
MS2 was not significantly affected by increasing the concentration of 53 kDa chitosan,
but it was significantly affected by increasing the concentration of 222 kDa. Increasing
the 222 kDa chitosan to 1.0% was sufficient to completely inactivate the virus. After
taking into account the effect of acid on MS2, the four concentrations of 53 kDa and 222
kDa chitosan caused between a 2.0-2.3 and 1.6- 4.15 log PFU/ml reduction, respectively,
(Figure 1, Table 1). Increasing the concentration of chitosan becomes effective against
MS2 once a certain MW is reached.

3.3 Effect of Chitosan on FCV-F9

The FCV-F9 titer was significantlyreduced by all tested concentrations for both
chitosans (53 and 222 kDa) compared to the controls. Increasing the concentration of 53
kDa from 0.7 to 1.5% did cause a significant increase in the reduction of FCV-F9 but it
was only a 0.27 log PFU/ml difference (Table 1). Chitosan of 222 kDa in concentration
of 0.7% reduced the titer for 2.22 PFU/ml compared to 0.95 PFU/ml in acidified control,
but increase in concentration did not further reduce FCV-F9 titer (Figure 1, Table 1).
Chitosan of 53kDa caused a more significant reduction of FCV-F9 than 222 kDa
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chitosan, which was similar to the trend found in our previous work on the effect of
molecular weight.

3.4 Effect of Chitosan on MNV-1

The recovery of MNV-1 was significantly reduced by all concentrations of both tested
chitosans with exception of 1.25% 53 kDa (Figure 1). The titer reduction caused by 53
and 222 kDa chitosan treatments ranged between 0.31-0.35 and 0.82-0.95 log PFU/ml,
respectively. Overall, increasing the chitosan concentration did not significantly affect the
reduction of MNV-1 for either MW. Although the reduction obtained was greater using
222 kDa compared to 53 kDa chitosan, the maximum reduction was still below 1 log
PFU/ml, and thus has little practical potential for application.

3.5 Discussion of chitosan concentration on antiviral effect

Bacteriophage MS2 showed the most vulnerability to chitosan. It showed similar
susceptibility for both molecular weights at 0.7 % concentration compared to the
previous study. Increasing the concentration only increased the antiviral activity for 222
kDa, which could be due to the large gap in MW between 53 kDa and 222 kDa. For phi
X174, increasing the concentration of chitosan for both MWs was not effective at
increasing the recovery of the virus. For FCV-F9, 53 kDa chitosan showed an increase in
antiviral activity as the concentration reached a certain parentage (1.25%), but the
antiviral activity for 222 kDa did not change with changes in concentration. MNV-1
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showed significant reductions in titers due to 222 kDa at all concentrations and 53 kDa at
all concentrations except 1.25%. Although, a clear trend of increasing antiviral activity
with increasing concentration cannot be seen for all the four viruses tested, lower
concentrations of chitosan do not appear to be more effective than the higher
concentrations of chitosan on any of the tested viruses. The inactivation mechanism by
chitosan needs to be examined to further explain the inactivation of viruses seen in this
research.
The antiviral activity has been shown to be dependent on the concentration of
chitosan in some earlier reports. Prospieszny et al. (1991) sprayed bean plants with
chitosan concentrations ranging 0.00001-0.1% 15 min before inoculation with alfalfa
mosaic virus and found increasing inhibition of the virus with increasing concentration
where complete inhibition at 0.01% was obtained. Another study showed the increase in
chitosan, chitosan acetate, and chitosan hydrochloride concentration from 0.00005 to
0.01% to cause an increase in infection inhibition from less than 50% to 100% against
bacteriophage T2 and T7 (Kochkina and Chirkov, 2000). Still another study found
conflicting results increased antiviral activity by increasing the concentration of chitosan
Su et al. (2009) found an increase in concentration from 0.175, 0.35, to 0.7% to cause a
statistically significant increase in the reduction of ~107 FCV-F9, which was 1.09, 2.09,
2.83 log PFU/ml, respectively, by 53 kDa chitosan and 0.44, 0.99, 1.44 log PFU/ml,
respectively, by 5 kDa chitosan. A similar trend was seen by 53 kDa chitosan against
~105 FCV-F9 and 5 kDa chitosan against ~107 and ~105 FCV-F9 and ~105 MNV-1 (Su et
al., 2009). Chitosan of 53kDa at 0.175% was shown to cause a statistically larger
reduction (0.32 log PFU/ml) of ~105 MNV-1 compared to 0.7% chitosan of 53 kDa (0.04
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log PFU/ml) (Su et al., 2009). Similarly, the same trend was seen for 53 kDa chitosan as
concentration decreased against ~107 MS2 and MNV-1 and for 5 kDa chitosan against
~107 MS2. Some viruses were not affected by an increase or decrease in concentration.
This was seen for 53 kDa chitosan against ~105 MS2 and for 5 kDa chitosan against ~105
MS2 and ~107 MNV-1 (Su et al., 2009). Still, more research needs to be done to
determine effect of the concentration on foodborne antiviral activity.
The concentration of chitosan has been shown to influence the antibacterial activity
against such organisms as Staphylococus aureus, Escherichia coli, S. Typhimurium and
Yersinia enterocolitica (Helander et al., 2001; Liu et al., 2004; Wang et al. 1992). Kong
et al. (2008) found the antibacterial activity of chitosan against E. coli to increase as the
concentration of 1456 kDa chitosan was increased from 0.02 to 0.1%. Liu et al. (2004)
and Zheng and Zhu (2003) found an increase in concentration ranging from <5 to 305
kDa to have increasing antibacterial action against of E. coli and S. aureus and ultimately
cause inactivation. Also, chitosan was found to disrupt the outer membranes of S.
Typhimurium at 0.01-0.025%, but did not kill it until reaching 2% (Helander et al.,
2001). The increase in antibacterial activity by chitosan due to an increase in
concentration has been found to occur at different rates depending on the type of bacteria,
such as Enterobacter aeromonas, E. coli, Bacillus cereus, Brochothrix thermosphacta,
Lactobacillus sakei, L. plantarum, Photobacterium phosphoreum, Pseudomonas
fluorescens, S. Typhimurium, and Y. enterocolitica (Devlieghere et al., 2004; Wang,
1992).
Chitosan concentration also seems to play an important role in the effectiveness of
antifungal activity. Increasing the concentration of chitosan concentration from 0 to 1.0%
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has been shown to increase the antifungal activity of chitosan against Botrytis cinerea
Candida albicans, C. krusei, C. glabrata, and Penicillium expansium (Liu et al., 2007;
Seyfarth et al., 2008). One study found that as the concentration of chitosan increased
from 2, 4, to 6% that the decay in strawberries was decreasing the decay by B. cinerea
(Reddy et al., 2000). Badaway et al. (2009) found that B. cinerea treated for 3 days at
25˚C with the concentrations ranging 0.05 to 0.4% of molecular weight ranging between
5 and29 kDa, the antifungal activity increased causing complete inactivation at 0.2% for
all molecular weights.

4. Conclusions

Increasing the concentration of chitosan from 0.7, 1.0, 1.25, to 1.5% was most
effective for 222 kDa chitosan against MS2, followed by 53 kDa against FCV-F9, while
ineffective for 53 kDa against MS2, for 222 kDa against FCV-F9, and for both chitosans
against phi X174 and MNV-1. The recovery of MS2 was reduced by 222 kDa chitosan as
the concentration of chitosan increased, with 1.0% being sufficient to completely reduce
the virus titer. The recovery of FCV-F9 was reduced by 53 kDa chitosan as chitosan
concentration increased to 1.25% or greater. Susceptibility of phi X174 and MNV-1 was
not concentration dependent. Overall, increasing the concentration either increases the
antiviral activity or does not change it. These results indicate that chitosan shows
potential as an antiviral agent in the food industry as a packaging material, coatings, or
sprays on crops, but the increasing the concentration above 0.7% does not appear to have
a major effect on viral inactivation.
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1. Figure 1. Effect of 0.7, 1.0, 1.25, and 1.5% chitosan in water or acetic acid (AcAc) on
the recovery of phi X174 (A), MS2 (B), FCV-F9 (C), and MNV-1 (D) using titers of ~5 log
PFU/ml. (

53 kDa at pH 5.6,

222 kDa at pH 4.5). Dark colored is recovery of virus

in PBS control after 0 and 3 hr. 53 kDa chitosan is water-soluble and therefore not
carried out using HCl or AcAc that were done for the 222 kDa chitosan.
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Table 1. Effect of pH controls with acetic (AcAc) and 0.7, 1.0, 1.25, and 1.5% of 53 and 222 kDa
chitosan in water or acetic acid on the reduction of phi X174 phage, MS2 phage, FCV-F9, and
MNV-1 using titers of ~5 log PFU/ml.

Reduction (log PFU/ml)
Treatment
Phi X174

MNV-1

0.00Cb ± 0.00

0.00Cd

± 0.00

0.00Dc

± 0.00

0.00Bb

±

0.00

AcAc cont.

0.47B ± 0.08

0.64B

± 0.09

0.47C

± 0.04

0.03B

±

0.04

0.69AB ± 0.15

2.61A

± 0.16

2.64B

± 0.02

0.31A

±

0.05

0.68AB ± 0.22

2.80A

± 0.17

2.62B

± 0.04

0.35A

±

0.14

0.86AB ± 0.17

2.77A

± 0.10

2.72AB

± 0.04

0.10B

±

0.07

0.94A ± 0.03

2.73A

± 0.09

2.91A

± 0.06

0.31A

±

0.05

0.70a ± 0.07

1.02c

± 0.10

0.95b

± 0.08

0.19b

±

0.08

0.51a ± 0.12

2.63b

± 0.14

2.22a

± 0.09

0.82a

±

0.11

0.60a ± 0.17

5.16a

± 0.00

2.30a

± 0.04

0.86a

±

0.07

0.58a ± 0.12

5.16a

± 0.00

2.34a

± 0.09

0.87a

±

0.05

0.75a ± 0.13

5.16a

± 0.00

2.41a

± 0.04

0.95a

±

0.07

1.0% 53 kDa
1.25% 53 kDa
1.5% 53 kDa
AcAc cont.
0.7% 222 kDa

4.5 pH

FCV-F9

3 hr control

0.7% 53 kDa
5.6 pH

MS2

1.0% 222 kDa
1.25% 222 kDa
1.5% 222 kDa

* Reductions with similar lowercase and uppercase letters are statistically simililar within the entire column.
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CHAPTER V
CONCLUSIONS AND RECOMMENDATIONS

In conclusion, chitosan was found to be efficient against MS2 and FCV-F9, while
it had no effect on phi X174 and MNV-1. Reduction of MS2 by chitosan increased as
molecular weight of chitosan increased, with high molecular chitosan (~1,150 kDa) being
able to completely inactivate the virus from ~105 log PFU/ml. The inactivation of FCVF9 and phi X174 were not molecular weight dependentwhile MNV-1, was not affected by
chitosan. Overall, the molecular weight does play a role in the antiviral activity of
chitosan against some of the tested viral surrogates.
Increasing the concentration of the chitosan showed varying affects on the four
enteric virus surrogates. Increasing the concentration of chitosan from 0.7 to 1.5% was
most effective for 222 kDa against MS2 and by 53 kDA against FCV-F9, while
ineffective for 53 kDa against MS2, for 222 kDa against FCV-F9, and for both MWs
against phi X174 and MNV-1. The infectivity of MS2 was completely inhibited by 1.0%
or more 222 kDa chitosan. The reduction of FCV-F9 was significantly increased by 53
kDa chitosan as the chitosan concentration improved to 1.25% or greater. Susceptibility
of phi X174 and MNV-1 was not concentration dependent.
The antiviral properties of chitosan depend on the type of virus and pH of the
media. Overall, MS2 was most susceptible, followed by FCV-F9, phi X174, and MNV-1.
The pH did have some effect on the recovery of all four surrogates. Lowering the pH
from 5.6 to 4.5 caused a greater reduction in all viral titers. MS2 was affected the most by
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the pH, followed by FCV-F9, phi X174, and MNV-1. However, comparing acetic and
hydrochloric acid, the type of acid was not found to significantly affect the recovery of
the any surrogates used in this research, except for MS2 and FCV-F9 with 222 kDa.
There is still need for research to determine the mechanism of antiviral activity of
chitosan. One potential way to further the understanding of chitosan‘s antiviral activity
would be to try the molecular weights (53 and 222 kDa) used in Chapter IV at lower
concentrations to determine the effect on these surrogates. As well as 307, 421, and
~1,150 kDa chitosan could be tried at both lower and higher concentrations to determine
their effect on these surrogates. Also, chitosan could be tried on different foodborne
viruses. Further research could be done on the effect of degree acetylation of chitosan
alone, degree acetylation combined with the concentration of chitosan, degree acetylation
combined with molecular weight of chitosan, and all three taken into account. Future
work should examine the interaction of chitosan and virus under the transmission electron
microscope.
Chitosan does show potential for use in the food industry. Along with the
antibacterial and antifungal properties of chitosan, it shows the potential to control the
spread of some enteric viruses. As an antiviral, chitosan can be most effective at
controlling the spread of viruses due to contamination from outside sources. As an
antimicrobial chitosan can be applied as a package material or as a pre- or post harvest
spray for crops that may become contaminated.
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